Blue Trust Inc’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,709
Closed -$61.1K 2651
2025
Q2
$61.1K Buy
6,709
+2,302
+52% +$17K ﹤0.01% 1278
2025
Q1
$39.8K Buy
4,407
+20
+0.5% +$211 ﹤0.01% 1462
2024
Q4
$57.3K Buy
4,387
+1,600
+57% +$21.3K ﹤0.01% 1227
2024
Q3
$37.6K Buy
2,787
+1,780
+177% +$27K ﹤0.01% 1684
2024
Q2
$27.9K Buy
+1,007
New +$20.6K ﹤0.01% 1518
2024
Q1
Sell
-242
Closed -$4K 2563
2023
Q4
$4K Buy
+242
New +$4.38K ﹤0.01% 1930
2023
Q2
Sell
-26
Closed 2379
2023
Q1
$0 Sell
26
-991
-97% -$17.8K ﹤0.01% 2537
2022
Q4
$24K Sell
1,017
-9
-0.9% -$176 ﹤0.01% 1237
2022
Q3
$33K Buy
1,026
+774
+307% +$23.9K ﹤0.01% 902
2022
Q2
$11K Buy
+252
New +$9.13K ﹤0.01% 1174

Other funds holding ACH

Blue Trust Inc's ACH Position: Q3 2025 in Review

Blue Trust Inc sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 6,709 shares — an estimated $61.1K sold.

Blue Trust Inc first reported a position in ACH in Q2 2022 and held it in 10 quarters. The position peaked at $61.1K in Q2 2025. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Blue Trust Inc reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • Blue Trust Inc sold 6,709 Accendra Health shares in Q3 2025, an estimated $61.1K.
  • Blue Trust Inc first reported a position in Accendra Health in Q2 2022 and held it in 10 quarters.
  • Blue Trust Inc's Accendra Health position peaked at $61.1K in Q2 2025.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Blue Trust Inc's 13F filing for Q3 2025, filed 16 Oct 2025.